Alternative Cancer Treatment

Hairy cell leukemia is a rare malignancy for which treatment has progressed significantly in recent years.

Rational minds, with full respect for scientific method, can reject inadequate scientific explanations; for example, the origin of the higher complexities of biological ...

Patients with bowel cancer who have stopped responding to a widely used targeted drug could benefit from immunotherapy, a major new study reveals.

Newcastle University killed a total of 40,114 animals in animal testing related experiments last year. A total of 15 procedures were carried out on macaque ...

Skyhawk and Merck will partner to discover and develop innovative RNA-binding small molecules that can form treatments for neurological diseases and ...

Advanced bowel cancer patients who have stopped responding to one of the main drugs used to treat it could be helped by immunotherapy, researchers have ...

Patients with bowel cancer who have stopped responding to a widely used targeted drug could benefit from immunotherapy, a major new study reveals.

Patients with bowel cancer who have stopped responding to a widely used targeted drug could benefit from immunotherapy, a major new study reveals.

Researchers at the University of Pennsylvania have found that men who take hormone-blocking therapy for prostate cancer may be at an increased risk for ...

Researchers at the University of Pennsylvania have found that men who take hormone-blocking therapy for prostate cancer may be at an increased risk for ...

Researchers at the University of Pennsylvania have found that men who take hormone-blocking therapy for prostate cancer may be at an increased risk for ...

A new drug for treating a type of blood cancer for patients who have had only one previous treatment has been recommended by the Scottish Medicines ...

Australians are being warned not to trust dodgy medical advice from Facebook and YouTube as former cancer patient Nikhil Autar declared bad advice almost ...

PLYMOUTH MEETING, Pa., July 8, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today that it has completed enrollment in its ...

The Progenics 2019 Annual Meeting is July 11, 2019.

A targeted drug has been accepted for routine use on the NHS in England for some adults with untreated, advanced lung cancer. But another precision drug, ...

Skyhawk will deploy its SkySTAR™ platform to develop drug candidates directed to multiple targets for neurodegenerative diseases and cancer. In exchange ...

Tara O'Neill Hayes explains how and why Medicare and Medicaid sometimes treat biosimilars as generics -- and sometimes don't.

Published: Jul 08, 2019. Tyler Jacks, Ph.D., head of the Koch Institute for Integrative Cancer Research at MIT, joins as Chair of Skyhawk's Scientific Advisory ...

Kicking off a new series to refresh your knowledge of red flags, respiratory consultant Dr Richard Turner takes you through features of a cough that you should ...